Man-Fung Yuen Selected Research

MicroRNAs (MicroRNA)

8/2011	The hepatitis B virus-associated estrogen receptor alpha (ERalpha) was regulated by microRNA-130a in HepG2.2.15 human hepatocellular carcinoma cells.
1/2011	Up-regulation of microRNAs, miR21 and miR23a in human liver cancer cells treated with Coptidis rhizoma aqueous extract.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Man-Fung Yuen Research Topics

Disease

160	Chronic Hepatitis B 05/2024 - 02/2002
71	Infections 05/2024 - 02/2002
65	Fibrosis (Cirrhosis) 05/2024 - 03/2002
62	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 03/2002
62	Hepatitis B 11/2023 - 01/2003
17	Neoplasms (Cancer) 12/2023 - 09/2002
16	Liver Cirrhosis (Hepatic Cirrhosis) 12/2022 - 12/2003
13	Hepatitis 09/2023 - 02/2002
11	Disease Progression 01/2023 - 08/2004
9	Liver Neoplasms (Liver Cancer) 10/2023 - 12/2003
9	Liver Diseases (Liver Disease) 01/2023 - 08/2004
8	Chronic Hepatitis C 01/2022 - 02/2002
7	Non-alcoholic Fatty Liver Disease 09/2023 - 07/2014
7	Viremia 01/2022 - 02/2002
6	Carcinogenesis 12/2023 - 05/2003
6	Fatty Liver 10/2023 - 01/2020
4	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2023 - 01/2018
3	Hypertension (High Blood Pressure) 10/2023 - 01/2022
3	Persistent Infection 01/2021 - 09/2008
3	Chronic Hepatitis (Chronic Active Hepatitis) 01/2021 - 01/2006
3	Neoplasm Metastasis (Metastasis) 11/2020 - 09/2002
3	Cholangitis 01/2020 - 07/2002
3	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2020 - 06/2017
3	Sepsis (Septicemia) 07/2019 - 10/2014
3	Stomach Neoplasms (Stomach Cancer) 10/2012 - 05/2003
2	Hepatitis C 10/2023 - 05/2018
2	Hepatitis E 01/2023 - 06/2004
2	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 11/2014
2	Fever (Fevers) 11/2022 - 01/2020
2	Diabetes Mellitus 01/2020 - 01/2019
2	Acute-On-Chronic Liver Failure 11/2019 - 07/2015
2	Substance-Related Disorders (Drug Abuse) 01/2018 - 09/2010
2	Coinfection 06/2017 - 01/2011
2	Inflammation (Inflammations) 01/2017 - 08/2013

Drug/Important Bio-Agent (IBA)

74	Hepatitis B Surface Antigens (HBsAg)FDA Link 04/2024 - 06/2004
69	DNA (Deoxyribonucleic Acid)IBA 05/2024 - 07/2002
66	Antiviral Agents (Antivirals)IBA 05/2024 - 03/2003
53	Hepatitis B e AntigensIBA 04/2024 - 11/2002
29	entecavir FDA Link 03/2024 - 01/2006
26	AntigensIBA 11/2023 - 06/2004
23	NucleosidesIBA 10/2023 - 12/2003
21	NucleotidesIBA 10/2023 - 11/2004
20	Lamivudine (Epivir)FDA Link 10/2017 - 07/2002
19	InterferonsIBA 01/2023 - 04/2003
18	Alanine Transaminase (SGPT)IBA 10/2023 - 11/2004
16	Biomarkers (Surrogate Marker)IBA 08/2023 - 12/2008
13	nasIBA 04/2024 - 01/2007
12	Tenofovir (Viread)FDA Link 05/2024 - 01/2011
12	Proteins (Proteins, Gene)FDA Link 10/2023 - 10/2012
10	RNA (Ribonucleic Acid)IBA 12/2023 - 02/2019
9	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022 - 03/2002
8	Ribavirin (Virazole)FDA LinkGeneric 10/2023 - 04/2003
8	BilirubinIBA 12/2021 - 03/2002
7	Telbivudine FDA Link 12/2019 - 09/2004
6	Circular DNAIBA 01/2022 - 10/2006
6	Immunoglobulins (Immunoglobulin)IBA 10/2017 - 10/2011
5	AlbuminsIBA 10/2023 - 08/2003
5	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2023 - 09/2002
5	adefovirIBA 12/2019 - 01/2009
4	CateninsIBA 12/2023 - 05/2003
4	Cadherins (E-Cadherin)IBA 12/2023 - 05/2003
4	Transaminases (Aminotransferases)IBA 01/2023 - 01/2006
4	Messenger RNA (mRNA)IBA 01/2022 - 10/2006
4	HLA-DP Antigens (HLA-DP)IBA 03/2014 - 01/2013
3	SodiumIBA 11/2023 - 11/2019
3	HDL CholesterolIBA 09/2023 - 01/2021
3	Viral ProteinsIBA 01/2023 - 11/2019
3	JNJ-56136379IBA 01/2023 - 01/2022
3	Reverse Transcriptase InhibitorsIBA 11/2022 - 09/2015
3	VaccinesIBA 12/2021 - 12/2008
3	Viral DNAIBA 01/2021 - 01/2017
3	BerberineIBA 08/2020 - 12/2015
3	((1- ((2- amino- 9H- purin- 9- yl)methyl)cyclopropyl)oxy)methylphosphonic acid dipivoxylIBA 01/2018 - 06/2014
3	hepatitis B hyperimmune globulinIBA 12/2015 - 06/2013
3	Interferon-alpha (Interferon Alfa)IBA 01/2013 - 06/2003
3	adefovir dipivoxil (Hepsera)FDA Link 01/2007 - 12/2003
2	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 01/2023
2	Nucleic AcidsIBA 11/2023 - 01/2021
2	TransferasesIBA 10/2023 - 01/2022
2	Protease Inhibitors (Protease Inhibitor)IBA 10/2023 - 05/2018
2	LDL CholesterolIBA 09/2023 - 07/2014
2	ProdrugsIBA 01/2023 - 05/2009
2	Toll-Like Receptor 7IBA 01/2023 - 01/2021
2	pgRNAIBA 01/2023 - 01/2021
2	Small Interfering RNA (siRNA)IBA 01/2023 - 11/2022
2	ARC-520IBA 01/2022 - 01/2020
2	Amino Acids FDA Link 01/2021 - 09/2016
2	Carrier Proteins (Binding Protein)IBA 03/2019 - 07/2017
2	Surface Antigens (Surface Antigen)IBA 01/2018 - 01/2012
2	huanglianIBA 12/2015 - 01/2011

Therapy/Procedure

95	Therapeutics 04/2024 - 02/2002
21	Liver Transplantation 09/2023 - 01/2003
7	Duration of Therapy 04/2024 - 08/2008
4	Aftercare (After-Treatment) 04/2024 - 01/2011
3	Retreatment 08/2023 - 01/2023
3	Drug Therapy (Chemotherapy) 01/2023 - 11/2014
3	Renal Replacement Therapy (Therapies, Renal Replacement) 07/2019 - 02/2002
2	Glycemic Control 11/2023 - 01/2023
2	RNAi Therapeutics 11/2023 - 10/2023
2	Withholding Treatment 01/2021 - 04/2015